Replies to post #150222 on Biotech Values

[masterlongevity]

can you explain how the MOA relates to AD? I can't, and that makes me skeptical

[DewDiligence]

Alzheimer's/Gammagard—…I would think it has better odds than most people think.

I agree, but that’s not saying much unless you quantify it. Many investors think Gammagard has no chance whatsoever in AD.

[DewDiligence]

BAX completely dodges pricing issue on Gammagard for AD during Q&A session.